Robert E. Reiter, MD, MBA, presented “Molecular Imaging For Staging and Advanced Disease – Axumin and PSMA” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.
How to cite: Reiter, Robert E. “Molecular Imaging For Staging and Advanced Disease – Axumin and PSMA” January 23rd, 2020. Accessed Mar 2021. https://grandroundsinurology.com/molecular-imaging-for-staging-and-advanced-disease-axumin-and-psma/
Molecular Imaging For Staging and Advanced Disease – Axumin and PSMA – Summary:
Robert E. Reiter, MD, Bing Professor of Urology and Molecular Biology, Director of the Prostate Cancer Program, and Director of Urologic Research at the David Geffen School of Medicine at the University of California, Los Angeles, discusses the benefits of PSMA imaging in the context of biochemical recurrence. He reviews data from an Australian and an American study which both depict a positive correlation between PSA levels and PSMA prostate cancer detection rates, as well as high sensitivities for detection of recurrence based on pathologic confirmation. He then discusses the results of a study which compared PSMA with Axumin and found PSMA to be more than twice as effective in all areas but the prostate bed, which is most likely due to PSMA being excreted through the bladder. He argues that PSMA imaging can produce between a 29% and 76% change in prostate cancer management and allows for greater precision in treatment, resulting in fewer occurrences of unnecessary radiation therapy and long term systemic therapy.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Reiter gave this presentation during the 30th iteration of the meeting in January 2020.
For further educational activities from this conference, visit our collection page.